|
UHRF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.52530000002904E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.32549999976028E-07 |
| Normal-vs-Stage2 |
1.279570E-02 |
| Normal-vs-Stage3 |
9.866400E-02 |
| Normal-vs-Stage4 |
1.153980E-01 |
| Stage1-vs-Stage2 |
6.783000E-01 |
| Stage1-vs-Stage3 |
1.378990E-01 |
| Stage1-vs-Stage4 |
1.509590E-01 |
| Stage2-vs-Stage3 |
4.260800E-01 |
| Stage2-vs-Stage4 |
4.449200E-01 |
| Stage3-vs-Stage4 |
9.929600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.75790000000498E-05 |
| Normal-vs-AfricanAmerican |
9.016100E-04 |
| Normal-vs-Asian |
1.701560E-01 |
| Caucasian-vs-AfricanAmerican |
1.501180E-01 |
| Caucasian-vs-Asian |
2.252600E-01 |
| AfricanAmerican-vs-Asian |
2.718400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.610200E-04 |
| Normal-vs-Female |
5.76230000000066E-05 |
| Male-vs-Female |
1.794440E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.054580E-01 |
| Normal-vs-Age(41-60Yrs) |
2.2387999998319E-07 |
| Normal-vs-Age(61-80Yrs) |
7.701200E-03 |
| Normal-vs-Age(81-100Yrs) |
4.599200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.157000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.867600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.346800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.338200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.521560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.451400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.46159999999218E-05 |
| Normal-vs-Grade 2 |
5.07039999986247E-08 |
| Normal-vs-Grade 3 |
2.365600E-02 |
| Normal-vs-Grade 4 |
2.278200E-01 |
| Grade 1-vs-Grade 2 |
3.841200E-03 |
| Grade 1-vs-Grade 3 |
7.6114000002736E-07 |
| Grade 1-vs-Grade 4 |
2.041900E-03 |
| Grade 2-vs-Grade 3 |
5.356000E-04 |
| Grade 2-vs-Grade 4 |
3.811400E-01 |
| Grade 3-vs-Grade 4 |
6.800200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.01340002845296E-09 |
| Normal-vs-ccB subtype |
7.582500E-02 |
| ccA subtype-vs-ccB subtype |
1.183660E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.34810000000674E-05 |
| Normal-vs-N1 |
4.327000E-01 |
| N0-vs-N1 |
4.233700E-02 |
|
|
